Navigation Links
Former FTC Attorney Christine White Joins Crowell & Moring's Health Care and Antitrust Groups
Date:1/30/2008

WASHINGTON, Jan. 30 /PRNewswire-USNewswire/ -- Crowell & Moring LLP is pleased to announce the addition of partner Christine L. White to its New York office as a member of the firm's Antitrust and Health Care groups. White joins from Bingham McCutchen LLP, where she helped found and co-chair the firm's Healthcare Industry Group. White is also a former staff attorney for the Federal Trade Commission (FTC), where she investigated and prosecuted mergers, joint ventures, and conduct cases involving health care entities. White's extensive experience in antitrust counseling and litigation will augment the firm's premier Health Care and Antitrust groups.

"Chris offers clients the in-depth experience that comes from working as both a government antitrust enforcer and trusted advisor to many of America's leading health care providers and payors. The combination of her public and private health care antitrust experience positions her to handle critical transactions and represent clients in government investigations and complex private litigation," said John T. Brennan, Jr., chair of Crowell & Moring's Health Care Group.

White concentrates her practice on antitrust counseling, antitrust civil litigation, and trade regulation matters. She provides counseling on a range of antitrust issues, including mergers, joint ventures and other collaborations among competitors in diverse industries. She has represented corporate, trade association and health care industry clients, such as local and national health care systems, multi-institutional systems, hospital districts, third party payors, provider network organizations, physician groups, and long-term care facilities. She also has represented medical device and pharmaceutical companies.

"Crowell & Moring offers my clients the opportunity to draw from among the largest and most esteemed health care and antitrust legal practices in the country. Health care clients require highly focused counsel from a
'/>"/>

SOURCE Crowell & Moring LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music
2. Sharing Miracles Television Program Extends Reach Across America: First Episode Features Former White House Press Secretary Tony Snow
3. Presidential Candidate and Former Arkansas Governor Mike Huckabee to Be Keynote Speaker for Hope International Universitys Celebrate Hope Dinner at Disneyland(R) Hotel
4. Former NFL Star Tiki Barber and CURE Founder Susan Axelrod Speak Out About Epilepsy on TODAY Show
5. MedcomSoft appoints former U.S. presidential health advisor, James Haveman, to health Care advisory board
6. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice
7. Brain patterns of former anorexics reveal clues to disorders lasting impact
8. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
9. Puget Sound Komen for the Cure, Former First Lady Mona Locke, Washington Health Leaders and Breast Cancer Survivors Call for Action to Reduce States High Breast Cancer Incidence
10. Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy
11. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... Pa. (April 24, 2014) - Contact lenses coated with an ... lens-related infections, reports a study in Optometry and ... Academy of Optometry . The journal is published by ... Wolters Kluwer Health . , Studies in animals and now ... the antimicrobial peptide melimine, according to the new research by ...
(Date:4/24/2014)... before, during and after colorectal surgery cut hospital stays ... researchers who led a study of the approach at ... is easier on patients before surgery, doing away with ... prescribed. After surgery, patients are encouraged to eat and ... recoveries. , Among findings published in the May 2014 ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... the corresponding terminology, and the relevance of palliation ... publications on randomized controlled trials (RCTs). This is ... Institute for Quality and Efficiency in Health Care ... report. , Together with external experts, IQWiG analysed ... lung cancer, malignant melanoma, and pancreatic cancer. For ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
Breaking Medicine News(10 mins):Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3
... ... Success”- a new DVD , Parents with teenagers who lack motivation and direction can now ... , ... 19, 2010 -- Parents with teenagers who lack motivation and direction can now access a ...
... matched the real personalities of the profile users , ... that Internet users favor idealized virtual identities, a new ... such as Facebook create profiles that stick closely to ... be more interested in fostering real communication and connections ...
... ... ... ... ...
... ... Morristown motorist and developed tinnitus, or severe ringing in her ears; she was granted compensation ... ... mail carrier represented by East Tennessee attorney Brack Terry of Terry, Terry & Stapleton ...
... ... snap. After one of the coldest Januarys in thirty years typical gas and electricity bills are ... ... energy bills of more than £200 this month because of the cold snap. After one of ...
... Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate ... and wrist enabling more targeted therapies unique to each ... of the American Journal of Roentgenology . Contrast-enhanced ... internal bodily structures. Rheumatoid ...
Cached Medicine News:Health News:Teen Motivation - with the 'Formula for Success' - a New DVD 2Health News:Facebook Profiles Don't Stretch the Truth 2Health News:Facebook Profiles Don't Stretch the Truth 3Health News:Facebook Profiles Don't Stretch the Truth 4Health News:MDS Announces Substantial Issuer Bid 2Health News:MDS Announces Substantial Issuer Bid 3Health News:MDS Announces Substantial Issuer Bid 4Health News:MDS Announces Substantial Issuer Bid 5Health News:MDS Announces Substantial Issuer Bid 6Health News:East Tennessee Attorney Brack Terry Obtains $120,000 Jury Award For Injured Mail Carrier 2Health News:It's Snow Joke as UK Gas and Electricity Bills Hit Record Highs -- Energyhelpline Calls for “Significant” Price Cuts 2Health News:Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis 2
(Date:1/15/2014)... IRVING, Texas , Jan. 15, 2014  Novation, the ... company, awarded several new IT value-added reseller (VAR) national ... with IT goods and services at lower costs. These ... value-added services such as initiative assistance and ongoing IT ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... MicroDose Technologies,Inc. (MicroDose) today announced that the first ... Inc., through a Merck affiliate, has been,achieved, triggering ... MicroDose,s dry powder inhaler (DPI) technology announced in ... of a Phase I clinical,study of an investigational ...
... -Trial to Examine New Therapeutic Platform in Patients with Cystoid Macular ... ... SUNNYVALE, Calif., Aug. 5 Icon Bioscience, Inc., (IBI),a privately ... its Phase I clinical trial to assess the,safety and efficacy of ...
Cached Medicine Technology:MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc. 2Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 2
Angled for temporal approach. Wire 14 mm rounded blades for patient comfort. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Angled upward 45 degrees for temporal approach. Open 14 mm blades....
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: